The key genes for CSCs to maintain stemness, such as OCT4, SOX2, and NANOG, were also significantly decreased after the combination treatment (Fig. 2C and D), further implying that the stemness of CSCs was reduced and different from that of normal tumor cells. This evidence concerns the gene POU5F1 and neoplasm.